A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel D. Karp, MD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Besançon
Besançon, France
- Bordeaux
Bordeaux, France
- Caen
Caen, France
- Clermont-Ferrand
Clermont-Ferrand, France
- Marseille
Marseille, France
- Nice
Nice, France
- Paris
Paris, France
- Rennes
Rennes, France
- Arizona
Phoenix, Arizona, United States
- Tucson
Tucson, Arizona, United States
- Duarte
Duarte, California, United States
- Colorado
Aurora, Colorado, United States
- Jacksonville
Jacksonville, Florida, United States
- Orlando
Orlando, Florida, United States
- Indianapolis
Indianapolis, Indiana, United States
- Boston
Boston, Massachusetts, United States
- Minneapolis
Minneapolis, Minnesota, United States
- Rochester
Rochester, Minnesota, United States
- Omaha
Omaha, Nebraska, United States
- Albuquerque
Albuquerque, New Mexico, United States
- Brooklyn
Brooklyn, New York, United States
- New York
New York, New York, United States
- Durham
Durham, North Carolina, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Seattle
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2014
- Primary completion
- 1 Aug 2024
- Completion
- 1 Apr 2025
- Last update posted
- 5 Apr 2024
- Registered enrollment
- 109
- Registry id
- NCT02266745
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.